tirzepatide approval for weight loss FDA Zepbound: FSU researcher available for context on newly approved treatment Tirzepatide for Weight Loss |

Reported side effects include GI upset, headache, and rarely, anaphylaxis with IV administration

The development of GLP-1 RA-specific medical nutrition therapy (MNT) protocols, and the active involvement of an RDN in optimizing key dietary recommendations, including ensuring adequate protein intake (based on g/kg body weight rather than percentage of total energy), increasing fiber intake, and reducing saturated fat intake, is important

Zuriarrain in his Miami practice

It also says anyone pregnant or breastfeeding, with liver disease, or taking immunosuppressants should discuss melatonin with a provider first, and notes melatonin may interact with blood thinners and diabetes medications

Neonatal herpes simplex virus infections

However, it is important to be cautious to prevent any unwanted complications